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IntroductIon
Melanocortin receptor 4 (MC4R) is a key element in hypotha-
lamic control of short- and long-term energy homeostasis by 
integrating signals provided by α-melanocyte-stimulating hor-
mone (α-MSH), an MC4R agonist, and Agouti-Related Peptide 
(AgRP), an MC4R inverse agonist (1–4). The central melano-
cortin system contains several neuronal circuits including lep-
tin-sensitive neurons expressing proopiomelanocortin (Pomc) 
or Agrp in the arcuate nucleus, brainstem neurons expressing 
Pomc, and downstream targets of these neurons expressing 
melanocortin receptor 3 (Mc3r) and Mc4r (5). In short, a posi-
tive energy state activates anorexigenic α-MSH signaling and 
represses expression of orexigenic Agrp, thus increasing energy 
expenditure and lowering caloric intake through increased 
downstream MC3R and MC4R signaling, whereas a negative 
energy state triggers opposite events.
In humans, haploinsufficiency of Mc4r is the most common 
monogenic cause of severe obesity, accounting up to ~3% of 
all cases (6–9). Human genome-wide association studies have 
demonstrated that single-nucleotide polymorphisms in MC4R 
or genetic variances near MC4R are highly associated with 
increased BMI, adipose mass, early-onset obesity, and risk to 
develop obesity (10–13). Moreover, about 150 MC4R mutations, 
predominantly with a negative effect on MC4R function, have 
been reported to date in humans (reviewed in ref. 5). In addi-
tion, targeted disruption of Mc4r in mice resulted in increased 
food intake, body weight, body length, serum hormone levels, 
lean mass, and white adipose tissue (WAT) levels (14). Finally, 
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these Mc4r−/− mice show an identical clinical syndromal pic-
ture as compared to human patients with mc4r haploinsuffi-
ciency (14–16).
In this study, we present the first functional knockout rat 
model for Mc4r, which was identified in a recent N-ethyl-N-
nitrosourea (ENU)-mutagenesis screen in our lab (17). We 
observed an ENU-induced premature stop codon in helix 8 of 
the G-protein-coupled receptor (Mc4rK314X), and we hypoth-
esized that this mutation would result in loss of function as 
the  mutated  MC4RK314X  misses,  amongst  other  important 
amino acids, two C-terminal isoleucines that are essential for 
correct receptor function (18). Therefore, we tested the func-
tionality of the mutated receptor in vitro, and performed a 
basic characterization of rats heterozygous (Mc4r+/K314X) and 
homozygous (Mc4rK314X/K314X) for the mutation. Furthermore, 
we tested the effect of Agouti-Related Protein79–129 (AgRP79–129), 
an MC4R inverse agonist, on feeding behavior and the effect 
of Melanotan-II (MTII; ref. 19), an MC4R agonist, on feeding 
behavior and grooming behavior in Mc4rK314X/K314X rats. Finally, 
we investigated whether Mc4rK314X/K314X rats demonstrated a 
changed substrate preference when offered a high-fat/high-
sucrose (HFHS) choice diet.
Methods and Procedures
animals
The Animal Care Committee of the Royal Dutch Academy of Science 
approved all experiments according to the Dutch legal ethical guide-
lines. The Mc4r mutant rat line (Mc4r1Hubr) was generated by target-
selected ENU-driven mutagenesis (see ref. 17), and high-throughput 
resequencing of genomic target sequences in progeny from mutagenized 
rats (Wistar/Crl background) revealed an ENU-induced premature 
stop codon in helix 8 (K314X) of Mc4r. The heterozygous mutant rat 
was backcrossed to wild-type Wistar background for six generations to 
eliminate confounding effects from background mutations induced by 
ENU as described before (20). To further control for possible contri-
butions of confounding mutations, we repeated several measurements 
in different outcross generations and could replicate previous findings 
in each generation. Additionally, we always compared littermates that 
were generated by crossing Mc4r+/K314X rats. Experimental rats were 
obtained at the expected Mendelian frequency. Mc4rK314X/K314X rats were 
viable into adulthood and appeared phenotypically normal despite their 
increased body weight. Two rats were housed together, unless noted 
otherwise, under controlled experimental conditions (12-h light/dark 
cycle, light period 0600–1800 hours, 21 ± 1 °C, ~60% relative humid-
ity). Standard fed chow diet (semi high-protein chow: RM3, 27% crude 
protein, and 12% fat, 3.33 kcal/g AFE; SDS, Witham, UK) and water 
was provided ad libitum unless noted otherwise. All rats had access to 
home-cage enrichment (red rat retreat; Plexx, Elst, the Netherlands and 
aspen gnaw brick; Technilab-BMI, Someren, the Netherlands), unless 
noted otherwise. Only male rats were used in this study.
rat genotyping
DNA isolation and genotyping were performed as described previously 
(21). In brief, a fragment of Mc4r, containing the ENU-induced muta-
tion was amplified using gene-specific primers (forward (F):CCCAA 
CTTCT ACAGG CAGAC; reverse (R): TGGTA ATGAG GCAGA 
TGATG) and a touchdown PCR cycling program (92 °C for 60 s; 12 
cycles of 92 °C for 20 s, 65 °C for 20 s with a decrement of 0.6 °C per 
cycle, 72 °C for 30 s, followed by 20 cycles of 92 °C for 20 s, 58 °C for 20 s, 
and 72 °C for 30 s; 72 °C for 180 s; GeneAmp9700; Applied Biosystems, 
Foster City, CA). The PCR reactions were diluted with 25 µl water, and 
1 µl was used as template for the dideoxy sequencing reactions, which 
were preformed according to the manufacturer instructions (Applied 
Biosystems). Sequencing products were purified using Sephadex G50 
(superfine, coarse; Sigma, Zwijndrecht, the Netherlands) mini-col-
umns and analyzed on a 96-capillary 3730XL DNA analyzer (Applied 
Biosystems). Sequences were analyzed for polymorphisms using poly-
phred (22) and manual inspection of the mutated position. All pups 
were genotyped around postnatal day (PND) 21. Genotypes were con-
firmed when experimental procedures were completed.
In vitro membrane expression and caMP response
N-terminally hemagglutinin (HA)-tagged MC4RWT and MC4RK314X con-
structs were cloned into the pcDNA3.1 expression vector (Invitrogen, 
Carlsbad, CA) and membrane expression of the HA-tagged receptors 
was tested in HeLa cells as described before (17). In vitro membrane 
expression data shown are general representation of observed results. 
MC4RK314X functionality was tested using a LacZ reporter-gene assay 
as previously described (23). Briefly, HEK293 cells co-transfected with 
either Cre::LacZ and pcDNA3.1-HA-Mc4rWT or with Cre::LacZ and 
pcDNA3.1-HA-Mc4rK314X were allowed to grow in a 96-well plate for 48 h. 
Subsequently, cells were incubated with the appropriate concentration 
α-MSH or forskolin (intrinsic activation of cyclic AMP (cAMP), used 
as positive control) in serum free Dulbecco’s modified Eagle’s medium. 
Dulbecco’s modified Eagle’s medium was discarded after 5  h of incuba-
tion, lysis buffer was added, and plates were stored directly at −20 °C. 
After defrosting the suspension, the substrate mix was added (1.6 g/
liter  o-nitrophenyl  β-d-galactopyranoside  with  β-mercaptoethanol 
(67.5 mmol/l), and MgCl2 (1.5 mmol/l) in phosphate-buffered saline). 
Light absorbance was measured at 405 nm. The experiment was done 
in triplo per genotype and data is shown as average.
a receptor-binding competition assay using 125I-ndP-α-Msh
In vitro MC4R binding was measured by co-transfecting HEK293 cells 
with 7 µg of pcDNA-HA-MC4RWT or pcDNA-HA-MC4RK314X in com-
bination with 400 ng TK-Renilla luciferase DNA. After 24 h of incuba-
tion, cells were split in two aliquots and one aliquot was treated with 
the indicated concentration of competing cold [Nle4, D-Phe7]-α-MSH 
(NDP-α-MSH) in combination with a stable concentration of the radio 
ligand 125I-NDP-α-MSH (7,000 counts per minute per well; both pep-
tides diluted in Ham’s F10 medium (Gibco) with 2.5 mmol/l CaCl2, 
0.25% bovine serum albumin, and 200 KIU/ml aprotinin supplement) 
supplemented with Tris-buffered saline containing 2.5 mmol/l CaCl2 
for 30 min at room temperature. The second aliquot was used to meas-
ure Renilla activity for transfection efficiency calculation and raw data 
corrections. The data are expressed in counts per minutes (cpm) and 
was measured in a lysed (using 1 M sodium hydroxide) cell suspension 
using a γ-counter. The experiment was done in triplo per genotype and 
data are shown as average.
Body composition
Starting at PND 33, rat body weight was measured weekly. For relative 
body weight, average body weight of wild-type rats was set at 100% 
and average body weight of Mc4rK314X/K314X rats was expressed as a per-
centage of average wild-type body weight. At PND 96, left and right 
subcutaneous and perirenal WAT fat pads were isolated and weighted. 
Subsequently, perirenal WAT pads were fixed in 4% formaldehyde, 
rotated overnight at room temperature, washed with phosphate-buff-
ered saline, and rinsed in 70% ethanol for at least 1 h. WAT pads were 
processed to paraffin (96% ethanol for 2 h, 2× 100% ethanol for 1.5 h, 
xylene for 2 h and embedded in paraffin overnight), cut to 14 µm sec-
tions, and stained with eosin. Adipocyte size of the perirenal WAT was 
calculated using NIH Image J software (Bethesda, MD). Per genotype, 
three rats were analyzed (10 pictures per rat, each picture taken at a 
different morphological site).
Plasma hormone levels
At PND 96, blood samples were collected after decapitation. Plasma 
insulin and leptin levels were measured as described before (20).614  VOLUME 20 NUMBER 3 | MaRch 2012 | www.obesityjournal.org
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Basal food intake measurements
Starting at postnatal day (PND) 49, rats were housed individually and 
food intake, water intake, and body weight were measured during 
PND 56–63.
Bomb calorimetry
During basal food intake measurements, fecal samples were collected 
between PND 59 and 63, freeze-dried, and analyzed for gross energy 
content using adiabatic bomb calorimetry (IKA Calorimeter System 
C4000; IKA, Heitersheim, Germany). The feed conversion efficiency 
was calculated as the body weight gain (g) divided by the effective 
energy intake (kcal; kcal ingested minus kcal lost in feces) per day.
ambulatory activity
Starting at PND 70, rats were allowed to habituate to the experimen-
tal room for 24 h before placement in a Phenotyper home-cage moni-
toring  system  (Noldus  Information  Technology,  Wageningen,  the 
Netherlands). After 20 h of acclimatization to the Phenotyper cages, 
basal ambulatory activity was measured during 24 h. Data were ana-
lyzed using Ethovision software (Noldus Information Technology) in 
combination with in-house developed software.
hypothalamic mrna expression
Ad libitum-fed rats were killed at PND 182 during the early afternoon 
and the hypothalamus was rapidly dissected and snap-frozen in liquid 
nitrogen. Hypothalamic mRNA expression was measured exactly as 
described before (20), with the addition that DNA was removed from 
the RNA samples using DNAse (Promega) as described by the manufac-
turer (Mc3r is a single exon gene). Primers were designed using SciTools 
PrimerQuest  (IDT):  Cyclophilin  (F:  ACTT  CATG  ATCC  AGGG 
TGGA GACT; R: AAGT TCTC ATCT GGGA AGCG CTCA), Pomc 
(F: TCCA TAGA CGTG TGGA GCTG GT; R: TTCA TCTC CGTT 
GCCT GGAA ACAC), Cartpt (F: TGGA CATC TACT CTGC CGTG 
GAT; R: TTCC TGCA GCGC TTCA ATCT GCAA), Npy (F: AGAG 
GACA TGGC CAGA TACT ACTC; R: AATC AGTG TCTC AGGG 
CTGG ATC), and Mc3r (F: CATG TACT TCTT CCTG TGCA GCCT; 
R: AAGG TCAG GGAG TCGC TGTT GATA) Average Mc4rK314X/K314X 
rat gene expression from the two experiments is expressed as a percent-
age of average wild-type rat gene expression.
IcV cannula implantation
Starting at PND 89, rats were allowed to habituate to the experimen-
tal room and housed individually. The next day, rats were anesthe-
tized by subcutaneous injection of Hypnorm (1.0 ml/kg; 10 mg/ml 
fluanisone, 0.315 mg/ml fentanyl citrate; Janssen Animal Health, 
Beerse, Belgium) and pain was reduced by Carprofen (Pfizer Animal 
Health, New York, NY) intramuscularly administered (0.1 ml/100 g 
body weight). A 16-mm stainless gauge was implanted in the lateral 
ventricle  (stereotaxic  coordinates:  1.0 mm  posterior  and  2.0 mm 
lateral of the bregma) as described earlier (24). After surgery, rats 
received two intraperitoneal injections of 3 ml saline to aid recovery. 
Rats were allowed to recover for 9 days, during which rats were han-
dled frequently.
IcV administration of MtII and agrP79–129
At PND 99, body weight was measured and rats were placed on a 
caloric restriction for 6 h (12 till 6 pm). Directly after start of the dark 
phase (6 pm), rats were injected with 3 µl saline. Subsequently, food 
and water intake was measured for 22 h after which the body weight 
was measured again at the end of the experiment. This paradigm was 
repeated with the administration of 1 nmol/l MTII (PND 103; Tocris 
Bioscience, Bristol, UK) and 1 nmol/l AgRP79–129 (PND 106; Phoenix 
Pharmaceuticals, Burlingame, CA). Experimental peptides were dis-
solved in 3 µl saline.
Grooming assay
The grooming assay was done as described before (25). Briefly, at PND 
109 rats were transported from the in-house animal facility, to an 
  observation room 2 h before start of the behavioral test, during which 
rats had no cage enrichment, or access to food or water. Grooming 
was induced by ICV administration of 1 nmol/l MTII (dissolved in 
3 µl saline). In our experiments, the observation cage consisted of 
a  Phenotyper  home-cage  monitoring  system  (Noldus  Information 
Technology) in which rats were placed immediately after the ICV injec-
tion. Observation started 15 min after the injection and continued for 
50 min. Grooming was scored every 15 s during 50 min resulting in 
maximal 200 grooming scores. The grooming elements vibrating, face 
washing, body and genital grooming, body licking, scratching, and paw 
licking were scored. The grooming tests were performed during the 
early afternoon. After experimental handling, the rats were killed and 
correct implantation of the ICV cannula was checked using a Methylene 
Blue injection. Only data from rats with a correct cannula were used.
hFhs-choice diet
Rats were individually housed at PND 69 and received ad libitum access 
to standard fed semi high-protein diet and water. Body weight and food 
intake was monitored every 2 days for 10 days (between PND 69 and 
79). At PND 79, rats received access to a food dispenser with standard 
semi high-protein diet, a food dispenser with HF diet (45%-AFE, 20% 
crude protein, 45% fat, and 35% carbohydrates; 4.54 kcal/g AFE; SDS), 
one bottle of water, and one bottle of 30% sugar water (1.2 kcal/g). After 
6 days of acclimation to the novel diets, body weight and food intake 
was monitored every 2 days for 10 days (between PND 85 and 95). 
Dispensers and bottles were swapped every 2 days to control for side-
preference effects.
data analysis
All data are shown as mean ± SEM. All data were analyzed using a com-
mercially available statistical program (SPSS for Macintosh, version 16.0) 
and were controlled for normality and homogeneity. Figures 1d–f, 2a, 
4b, and 8a,b were analyzed using repeated measures analysis, followed 
by Bonferroni post hoc analyses if significant overall interactions were 
observed. Figure 3a–f was analyzed using one-way ANOVA, followed 
by Bonferroni post hoc analyses if significant overall interactions were 
observed. Figure 6a,b was analyzed using two-way ANOVA, followed 
by Bonferroni post hoc analyses if significant overall interactions were 
observed. All other data were analyzed using a Student’s t-test. The null 
hypothesis was rejected at the 0.05 level.
results
the Mc4rK314X mutation results in loss of function
We have recently described a mutation in the Mc4r gene in the 
rat (Mc4rK314X), which generates a premature stop codon and 
an 18-amino acid truncation in helix 8 of the receptor, thereby 
removing the C-terminus, which is essential for receptor cell 
surface localization (Figure 1a; refs. 17,18). Indeed, whereas 
HA-tagged  MC4RWT  was  clearly  detectable  at  the  plasma 
membrane of HeLa cells, HA-tagged MC4RK314X could not be 
detected at the plasma membrane (Figure 1b), confirming 
earlier observations (17). Permeabilization of transfected cells 
reconfirmed the presence of approximately equal expression 
levels of both wild-type and mutant HA-MC4R fusion proteins 
(Figure 1c), indicating that mutant MC4R is probably syn-
thesized but fails to be transported to the plasma membrane 
where it normally performs its function.
Using an in vitro cAMP assay, we show that HEK293 cells 
transfected with HA-tagged Mc4rK314X were unable to activate 
cAMP  after  addition  of  α-MSH,  whereas  cells  transfected 
with  HA-tagged  Mc4rWT  show  a  dose-dependent  response 
(Figure 1d). The statistical analysis for cAMP readout after 
α-MSH  treatment  revealed  a  significant  effect  of  dilution obesity | VOLUME 20 NUMBER 3 | MaRch 2012  615
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(F(11,99) = 22; P < 0.001), of genotype (F(2,9) = 418; P < 0.001), 
and a dilution × genotype interaction (F(22,99) = 34; P < 0.001; 
Figure 1d). To control whether the HA tag could have an 
effect on the assay we measured α-MSH response of HEK293 
cells transfected with non-HA-tagged Mc4rWT, which showed 
an equal cAMP readout as compared to HA-tagged Mc4rWT 
transfected cells when treated with the same dilution series 
of α-MSH or forskolin (data not shown). This demonstrates 
that the HA tag did not influence wild-type receptor activity. 
Furthermore, treatment with forskolin shows the same degree 
of cAMP activation in all tested conditions, demonstrating 
that an equal number of cells were transfected with the differ-
ent expression vectors (Figure 1e). The statistical analysis for 
cAMP readout after forskolin treatment revealed a significant 
effect of dilution (F(7,63) = 272; P < 0.001), but no effect of geno-
type (F(2,9) = 3; P = 0.11), and no dilution × genotype interac-
tion (F(14,63) = 1; P = 0.44; Figure 1e).
Finally,  we  demonstrated  that  HEK293  cells  transfected 
with HA-Mc4rK314X were unable to bind radioactive 125I-NDP-
α-MSH during a receptor-binding competition assay whereas 
a significant signal was detected for cells transfected with 
HA-Mc4rWT (Figure 1f). The statistical analysis for 125I-NDP-
α-MSH binding after cold NDP-α-MSH treatment revealed a 
significant effect of dilution (F(4,17) = 40; P < 0.001), of genotype 
(F(1,4) = 627; P < 0.001), and a dilution × genotype interaction 
(F(4,17) = 40; P < 0.001; Figure 1f).
the Mc4rK314X mutation results in obesity
Body weight analysis of rats during development revealed 
that Mc4rK314X/K314X rats developed early-onset obesity whereas 
Mc4r+/K314X rats developed late-onset obesity as compared to 
wild-type siblings (Figure 2a,b). The statistical analysis for 
body weight revealed a significant effect of time (F(9,261) = 2262; 
P < 0.001), an effect of genotype (F(2,29) = 20; P < 0.001), and a time 
× genotype interaction (F(18,261) = 38; P < 0.001; Figure 2a). At 
PND 96, average body weight of Mc4r+/K314X and Mc4rK314X/K314X  
rats was 493 ± 8 g (116 ± 2%) and 602 ± 12 g (141 ± 3%), 
respectively, as compared to   wild-type siblings (426 ± 15 g; 
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Figure 2a,b). Mc4rK314X/K314X rats displayed increased subcuta-
neous and perirenal WAT mass as compared to wild-type sib-
lings (405 ± 21% and 415 ± 18%, respectively; Figure 2c,d), 
both of which remained increased when normalized for body 
weight (291 ± 15% and 299 ± 15%, respectively; Figure 2c,d). 
Moreover, Mc4rK314X/K314X rats demonstrated increased perire-
nal adipocyte cell size (Figure 2e), increased plasma leptin 
levels (553 ± 47%; Figure 2f), and increased plasma insulin 
levels (372 ± 36%; Figure 2g) as compared to wild-type sib-
lings. Finally, an increase in body weight in Mc4r+/K314X and 
Mc4rK314X/K314X rats at PND 96 was accompanied by an increase 
in body length and waist circumference (Figure 2h,i).
the Mc4rK314X mutation results in hyperphagia
During  postnatal  week  9  (PND  56–63),  the  average  body 
weight of Mc4rK314X/K314X rats was increased as compared to 
wild-type siblings (125 ± 3% as compared to wild-type rats), 
whereas body weights did not differ significantly between 
Mc4r+/K314X and wild-type rats (98 ± 1% as compared to wild-
type rats; Figure 3a). Both Mc4r+/K314X and Mc4rK314X/K314X rats 
demonstrated increased food intake as compared to wild-type 
siblings, although the difference between Mc4r+/K314X and wild-
type rats was not significant (Figure 3b). Moreover, when food 
intake was normalized for body weight, both Mc4r+/K314X and 
Mc4rK314X/K314X rats were hyperphagic as compared to wild-type 
siblings (Figure 3c). Mc4rK314X/K314X rats also consumed more 
water as compared to wild-type siblings (see Supplementary 
Figure S1 online).
During PND 56–59, fecal output and fecal energy loss of 
Mc4rK314X/K314X rats were increased as compared to Mc4r+/K314X 
and wild-type siblings, whereas fecal output did not differ sig-
nificantly between Mc4r+/K314X and wild-type rats (Figure 3d,e). 
During these 3 days, the feed conversion efficiency did not differ 
significantly between wild-type, Mc4r+/K314X, and Mc4rK314X/K314X 
rats (Figure 3f).
the Mc4rK314X mutation decreases ambulatory activity
During  postnatal  week  10,  total  ambulatory  activity  of 
Mc4rK314X/K314X rats was decreased during the light phase, the 
dark phase, and during 24 h as compared to wild-type siblings 
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(Figure 4a,b). The statistical analysis for 24 h ambulatory activ-
ity revealed a significant effect of time (F(16,217) = 7; P < 0.001), 
of genotype (F(1,14) = 13; P < 0.005), but no time × genotype 
interaction (F(16,217) = 1; P = 0.61; Figure 4b).
the Mc4rK314X mutation affects hypothalamic  
gene expression
Because the hypothalamus is an important brain region regu-
lating energy balance, gene expression of Pomc, cocaine-, 
and amphetamine-regulated transcript (Cartpt), neuropep-
tide-Y (Npy), and Mc3r was investigated in hypothalamus 
samples of ad libitum-fed adult rats. At PND 182, relative 
hypothalamic gene expression of Pomc and Cartpt, both food 
intake-  suppressing  genes,  was  upregulated,  whereas  rela-
tive expression of Npy, a food intake-stimulating gene, was 
unchanged in Mc4rK314X/K314X rats as compared to wild-type rats 
(Figure 5). In addition, relative hypothalamic gene expression 
of Mc3r was increased in Mc4rK314X/K314X rats as compared to 
wild-type rats (Figure 5).
Pharmacological manipulation of the melanocortin  
system in vivo
Activation of MC4R decreases feeding, whereas blockade of 
MC4R increases feeding (26–28). Therefore, we tested whether 
Mc4rK314X/K314X rats change their feeding behavior in response 
to ICV administration of AgRP79–129, a nonselective MC3R and 
MC4R inverse agonist, or MTII, a nonselective MC3R and 
MC4R agonist (19). ICV administration of 1 nmol/l AgRP79–129 
increased the 22-h cumulative caloric intake in Mc4r+/+ rats 
as compared to saline-treated Mc4r+/+ rats, but had no effect 
on feeding in Mc4rK314X/K314X rats (Figure 6a). Furthermore, 
ICV administration of 1 nmol/l MTII lowered caloric intake 
in Mc4r+/+ rats as compared to saline-treated Mc4r+/+ rats, but 
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again had no effect on feeding in Mc4rK314X/K314X rats (Figure 6a). 
Finally, body weight growth of Mc4r+/+ rats was positive after 
AgRP79–129 administration and negative after MTII administra-
tion, whereas no robust effects were observed in Mc4rK314X/K314X 
rats (Figure 6b).
the MC4RK314X mutation abolishes MtII-induced  
grooming behavior
ICV administration of MTII induces grooming behavior in rats 
(29). Therefore, we tested whether Mc4rK314X/K314X rats increased 
their grooming behavior in response to ICV MTII administra-
tion. ICV administration of 1 nmol/l MTII resulted in excessive 
grooming behavior during a rat-grooming assay (87 ± 2% of 
experimental time spent on grooming behavior) in Mc4r+/+ rats, 
whereas this excessive behavior was absent in Mc4rK314X/K314X 
rats (8 ± 3% of experimental time spent on grooming behav-
ior; Figure 7). This demonstrates that melanocortin-induced 
grooming is exclusively mediated by MC4R.
the MC4RK314X mutation increases preference  
for hF substrate
Loss or blockade of MC4R signaling increases HF substrate 
consumption, changes preference towards an HF diet, and 
increases appetitive responding for a fat, but not a carbohy-
drate, reinforcer (30–32). Moreover, Mc4r−/− mice increase 
their body weight markedly as compared to wild-type siblings 
when fed a moderate-fat diet (33). Here, we gave Mc4r+/+ and 
Mc4rK314X/K314X rats, raised on a standard chow diet, access to a 
HFHS-choice diet and measured caloric intake and changes in 
body weight on both diets. Mc4rK314X/K314X rats increased their 
body weight slightly faster, albeit not significantly, during 10 
days on a chow diet as compared to wild-type rats. The statisti-
cal analysis for body weight growth on a chow diet revealed 
a significant effect of time (F(4,28) = 111; P < 0.001), but not of 
genotype (F(1,7) = 1; P = 0.42) and no time × genotype interac-
tion (F(4,28) = 2; P = 0.14; Figure 8a). However, on an HFHS-
choice diet, Mc4rK314X/K314X rats increased their body weight 
faster as compared to wild-type rats. The statistical analysis 
for body weight growth on an HFHS-choice diet revealed a 
significant effect of time (F(2,12) = 386; P < 0.001) but not of 
genotype (F(1,7) = 1; P = 0.39), and revealed a time × genotype 
interaction (F(2,12) = 6; P < 0.05; Figure 8b). Mc4rK314X/K314X rats 
ingested more calories on a standard chow diet as well as on an 
HFHS-choice diet as compared to wild-type siblings, although 
this difference was not significant when fed an HFHS-choice 
diet (Figure 8c). Both genotypes increased their total caloric 
intake, albeit not significantly, on an HFHS-choice diet as 
compared to a standard chow diet (Mc4r+/+: 120.4 ± 3.9%,   
Mc4rK314X/K314X: 114.4 ± 4.9%; Figure 8c). Finally, when fed 
an HFHS-choice diet, Mc4rK314X/K314X rats ingested equal calo-
ries from the standard chow substrate (Mc4r+/+: 35.5 ± 1.0%, 
Mc4rK314X/K314X:  38.6  ±  6.2%),  significantly  more  calories 
from the HF substrate (Mc4r+/+: 42.8 ± 1.6%, Mc4rK314X/K314X: 
53.7 ± 4.3%), and significantly fewer calories from the HS 
substrate as compared to wild-type rats (Mc4r+/+: 21.7 ± 1.8%, 
Mc4rK314X/K314X: 7.7 ± 2.1%; Figure 8d). This demonstrates that 
loss of MC4R function changes substrate preference toward 
HF energy-rich substrates.
dIscussIon
Taken together, our in  vitro  and  in  vivo da ta sho w tha t the 
Mc4rK314X mutation results in loss of function. We observed that 
the Mc4rK314X mutation abolishes correct membrane localization 
in vitro, and that Mc4rK314X/K314X rats demonstrated increased body 
weight, adipose mass, plasma hormone levels, body length, and 
basal food intake in combination with decreased ambulatory 
activity. ICV administration of AgRP79–129 or MTII had no robust 
effect on feeding behavior in Mc4rK314X/K314X rats. Furthermore, 
ICV MTII administration induced excessive grooming behavior 
in wild-type rats, whereas it had no robust effect on grooming 
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behavior in Mc4rK314X/K314X rats. Finally, when offered an HFHS-
choice diet, Mc4rK314X/K314X rats demonstrated increased preference 
for an HF substrate in combination with decreased preference for 
an HS substrate as compared to wild-type rats.
The in vitro data obtained with our rat model confirms ear-
lier observations that the C-terminus is essential for correct 
MC4R cell surface localization, and that subsequent loss of cell 
surface localization abolishes correct MC4R signaling (18). 
Moreover, mutation of one of the two C-terminal isoleucines 
(Ile-317-Thr) in a human proband results in severe overweight 
(34), indicating that our rat model is a bonafide animal model 
resembling loss of MC4R function in humans.
Functional loss of MC4R in the rat results in a gene dos-
age effect on body weight that showed strong overlap with 
data observed after Mc4r disruption in mice (14). Moreover, 
Mc4rK314X/K314X  rats  demonstrated  increased  body  length, 
increased food intake, increased plasma insulin and leptin lev-
els, and decreased 24 h ambulatory activity that are also in line 
with earlier observations in Mc4r-null mice (14,35). Finally, 
ICV administration of AgRP79–129 affected feeding behavior 
and ICV administration of MTII affected feeding and groom-
ing behavior in wild-type rats, both as expected (26,28,29,36), 
but these effects were absent in Mc4rK314X/K314X rats. In sum, 
our in vivo data confirm earlier observations in other rodent 
  models and indicate that the Mc4rK314X mutation results in 
functional loss of MC4R.
Hypothalamic  gene  expression  analysis  revealed  no  sig-
nificant changes in Npy expression, but an increased expres-
sion of Pomc, Cartpt, and Mc3r in adult Mc4rK314X/K314X rats as 
compared to wild-type siblings. Increased expression of Pomc 
was not observed in any hypothalamic brain region of Mc4r-
null mice, whereas increased expression of Npy was observed 
in the dorsal medial hypothalamic nucleus of Mc4r-null mice 
(14). Thus, more specific analysis of gene expression in indi-
vidual brain regions involved in the regulation of body weight 
might provide important information on differences between 
murine and rat models, and the processes underlying MC4R-
deficiency-induced obesity.
Mc3r−/− mice on a standard chow diet demonstrate normal 
body weights, albeit adiposity levels were increased in com-
bination with a lower lean mass as well as a decreased food 
intake (37). Furthermore, Mc3r and Mc4r double knockout 
mice demonstrated heavier body weights than single gene 
knockouts (37,38). Finally, recently it was shown that MC3R 
function has an effect, although subtle, on food intake (39). 
In sum, MC3R, which is generally considered an autoreceptor 
(40), affects energy homeostasis. Thus, the relative hypotha-
lamic upregulation of Mc3r observed in Mc4rK314X/K314X rats 
might result in compensatory effects.
Administration of MTII induces excessive grooming behav-
ior in wild-type rats (29), whereas Mc4rK314X/K314X rats do not 
display excessive MTII-induced grooming behavior. Moreover, 
the  time  spent  grooming  by  MTII-injected  Mc4rK314X/K314X 
rats did not significantly differ from time spent grooming by 
saline-injected wild-type rats during a comparable assay (data 
not shown; ref. 29). This indicates that MTII-induced groom-
ing behavior is activated exclusively through MC4R-specific 
pathways, and not via MC3R-specific pathways.
Loss or blockade of MC4R signaling increases HF substrate 
consumption,  changes  preference  towards  an  HF  diet,  and 
increases appetitive responding for a fat, but not a carbohydrate, 
reinforcer in rodents (30–32). Here, we show that functional 
loss of MC4R in the rat increases preference toward an HF sub-
strate and away from an HS substrate, when offered an HFHS-
choice diet. As the mechanism of these motivational changes is 
not yet fully understood, additional behavioral and molecular 
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experiments with Mc4rK314X/K314X rats on HF diets or on HFHS-
choice diets will be of interest. Finally, Mc4r−/− mice increased 
their body weight markedly as compared to wild-type mice when 
fed a moderate HF diet for 7 days, whereas body weight growth 
of Mc4rK314X/K314X rats on an HFHS-choice diet for 10 days did 
not differ markedly from wild-type rats. An explanation for this 
observation might lie in species-specific differences, or in the fact 
that Mc4rK314X/K314X rats had a substrate choice whereas Mc4r−/− 
mice had not. Therefore, a detailed analysis of the homeostatic 
response of Mc4rK314X/K314X rats to a (moderate) HF diet, without 
access to other substrates, will provide valuable information.
Given the amount of outcrossing to a wild-type background in 
our experimental Mc4rK314X/K314X rats and the strong phenotypic 
overlap between Mc4rK314X/K314X rats and Mc4r-null mice, we are 
confident that the observed phenotypes in Mc4rK314X/K314X rats 
solely result from functional loss of MC4R. Also, an alternative 
to the conclusion that functional loss of Mc4r directly influences 
energy metabolism is that loss of Mc4r could result in a defect 
in hypothalamic brain development resulting in hyperphagia 
and obesity. This argument is formally difficult to exclude; how-
ever, no gross neuroanatomical defects were observed in brain 
sections from Mc4rK314X/K314X rats. Furthermore, direct evidence 
for a pharmacological etiology is provided by the modulation 
of feeding behavior and body weight regulation by acute or 
chronic administration of MC4R agonists and antagonists, as 
described above.
We believe that the Mc4rK314X rat model will be of great value 
to study the cause of human monogenic obesity by adding 
the rat to the field of comparative genomics. Moreover, due 
to the increased size and cognitive performance of the rat as 
compared to mice, allowing for more complex surgeries and 
behavioral experiments, we believe that our rat model can help 
further understand the specific mechanisms that induce obes-
ity during loss of MC4R function.
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